Vasoconstrictor effects of endothelin-l (ET) were investigated in endothelium-denuded strips of cere bral (basilar and posterior cerebral) and mesenteric arter ies of the dog. ET produced a concentration-dependent contraction in these arteries. Contractile responses to lower concentrations (below 3 x 10 -10 M) of ET were significantly greater in the cerebral arteries than in the mesenteric artery. Inhibition by nifedipine of the contrac tile responses to ET was greater in the basilar artery than in the mesenteric artery. After the inhibition by 10-7 M nifedipine, the remaining responses to ET were similar in the two arteries. Cerebral arteries, but not the mesenteric artery, relaxed significantly from the resting level when placed in a Ca2 + -free solution containing 0.1 mM EGT A (O-Ca solution). Readdition of Ca2+ to the cerebral arter-
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interact with ion channels have suggested that ET causes vasoconstriction via accelerating Ca2 + in flux through voltage-dependent Ca2 + channels (VDCs) . In addition to these Ca2 + influx accelerating activities, ET has been shown to have multiple sites of action on vas cular smooth muscle including Ca2 + release from intracellular storage sites (Auguet et al., 1988; Miasiro et al., 1988; Resink et al., 1988; Van Rent erghem et al., 1988; Kai et al., 1989; Takuwa et al., 1989) and ET receptor-operated Ca2 + influx (Chabrier et al., 1989; Wallnofer et al., 1989) .
Since ET caused a potent and prolonged contrac tion in cerebral arteries of the cat and the dog (Asano et al., 1989b; Jansen et al., 1989; Saito et al., 1989; Kauser et al., 1990) , this peptide may play an important role in the pathogenesis of cerebral va sospasm (Asano et al., 1989b; Jansen et al., 1989; Robinson and McCulloch, 1990 ). Cerebral arteries have been shown to be more sensitive than periph eral arteries to dihydropyridine Ca2+ channel ago-nists (Asano et al., 1987) and blockers (Allen and Banghart, 1979; Shimizu et al., 1980; Towart, 198 1; Cauvin et al., 1983) . Therefore, to produce a con traction in cerebral arteries, the Ca2+ influx through VDCs plays a more important role than the Ca2+ release from intracellular storage sites. The present study was designed to determine whether the vasoconstrictor action of ET on cerebral arter ies was enhanced when compared with that on pe ripheral arteries. In the event of ET producing a more potent contraction in cerebral arteries, it was also the aim to determine the possible mechanism of the enhanced response to ET.
METHODS
Mongrel dogs of either sex weighing 7-12 kg were anes thetized with sodium pentobarbital (30 mg/kg i.v.) and exsanguinated. The brain and the mesenteric artery with an in situ outside diameter of 0.6-0.8 mm were removed and placed in physiological salt solution (PSS) of the fol lowing composition (in mM): NaCI, 115.0; KCI, 4.7; CaClz, 2.5; MgClz, 1.2; NaHC0 3 , 25.0; KH 2 P0 4 , 1.2; and dextrose, 10.0. Basilar (0.7-0.9 mm) and posterior cere bral (PC, 0.6-0.8 mm) arteries were isolated from the brain. Helical strips (0.8 mm in width and 7 mm in length) of these arteries were prepared as described previously (Asano et al., 1987 (Asano et al., ,1988 . To avoid the possible influ ences of the endothelium-derived factors (e.g., EDRF, EDHF, and EDCF), the endothelium of the strip was removed by gently rubbing the endothelial surface with cotton pellets. Successful removal of the endothelium was confirmed by the inability of acetylcholine (10-6 M) to induce relaxation (Asano et al., 1987) .
Arterial strips were mounted vertically between hooks in water-jacketed muscle baths containing 20 ml of the PSS. The PSS was maintained at 37"C and continuously aerated with 5% COz in Oz. The upper end of the strip was connected to a force-displacement transducer (TB-612T, Nihon Kohden Kogyo Co., Tokyo, Japan) for iso metric tension recordings. Strips were stretched pas sively to optimal length by imposing the optimal resting tensions (basilar, 0.8 g; PC, 0.6 g; mesenteric, 0.8 g). To determine the optimal resting tension, a length-passive tension study was performed (Asano et al., 1987) . After application of the resting tension, strips were equilibrated for 90 min in PSS with replacement of the solution every 20 min. These resting tensions were maintained through out the experiments. Mter the equilibration, contractile responses of the strips to the PSS containing 65.9 mM KCI (K+) (K+ substitution for Na+) were repeated two or three times until the responses were reproducible. The use of PSS containing 65.9 mM K + produced maximum contractions in both cerebral and mesenteric arteries (Asano et al., 1987) .
Cumulative concentration-response curves for the con tractile effects of ET were determined by a stepwise in crease in the concentration of ET as soon as a steady response to the preceding concentration had been ob tained. The concentration in the bath was increased by a factor of about 3 until the maximum response was ob tained. Contractile responses to ET are expressed as % of the contraction induced by PSS containing 65.9 mM K +.
J Cereb Blood Flow Metab, Vol. 11, No.3, 1991 The effect of nifedipine on the concentration-response curve for ET was determined in the following way. Two strips from the same animal were prepared and sUbjected to different treatments; test strips were treated with 10-7 M nifedipine for 40 min, while control strips were treated with the vehicle for nifedipine. One concentration response curve for ET was determined on each strip. The anatomical position of each strip was noted before it was assigned, using a balanced design, to one of two treat ments. The relaxant responses to nifedipine also were determined in strips precontracted with ET.
In some experiments, contractile responses to ET were determined in a Ca z + -free (O-Ca) solution. The O-Ca so lution was prepared by omission of Ca2 + from the PSS and EGT A in a concentration of 0.1 mM was added. When assessing the EC50 value, responses to ET were calculated as % of the maximum response obtained with ET. The EC50 value was obtained from a plot of % re sponse vs. log concentration of ET and expressed as a negative logarithm ( -log EC50). Unless specified, results shown in the text, table, and figures are expressed as means ± SD (n = number of preparations). Statistical analysis of the data was done by Student's t test for paired or unpaired data, or by completely randomized design, one-way analysis of variance followed by New man-Keuls test for a significant F ratio (p < 0.05), de pending on which test was statistically appropriate. Two groups of data were considered to be significantly differ ent when p < 0.05.
The drugs used were endothelin-l (ET) (Peptide Insti tute Inc., Osaka, Japan), nifedipine (a kind gift from Bayer Yakuhin Ltd., Osaka, Japan), and EGTA (Sigma Chemical Co., St. Louis, MO, U.S.A.). ET was dissolved in 0.025% acetic acid to make a stock solution of 10-4 M with further dilution in PSS before use. This concentra tion of acetic acid had no effect on the arterial prepara tions used. Nifedipine was dissolved in 50% ethanol to make a stock solution of 10 -3 M with further dilution in distilled water before use. Concentrations of drugs are expressed as final molar concentrations in the muscle bath.
RESULTS

Contractile res p onses to ET
Maximum contractile responses to 65.9 mM K + in strips of basilar, PC, and mesenteric arteries were 1, 170 ± 320 mg (n = 15), 956 ± 283 mg (n = 15), and 1,446 ± 375 mg (n = 15), respectively. After determination of the contractile response to 65.9 mM K +, the addition of ET in concentrations ranging from 1 x 10 -11 to 1 x 10 -7 M caused a concentration-dependent contraction in strips of these arteries (Fig. 1) . The response was slow in onset and long lasting. Contractile responses to lower concentrations (below 3 x 10 -1 0 M) of ET in the basilar and PC arteries were significantly greater than those in the mesenteric artery. The -log EC50 value for ET was significantly larger in the basilar (9.23 ± 0.27, n = 15) and PC (9. 13 ± 0. 3 1, n = 15) arteries than in the mesenteric artery (8.85 ± 0.26, n = 15). Maximum contractions in- duced by ET (3 X 10 -8 M) were similar among these arteries ( Fig. 1 ).
Effects of nifedi p ine on the contractile res p onses to ET
The addition of 10-7 M nifedipine caused a sus tained relaxation in strips of the basilar artery ( Fig.  2 left, broken line), but not in the mesenteric artery. The magnitude of the basilar arterial relaxation in duced by nifedipine was 21.2 ± 8.2% (n = 7) of the contraction induced by 65.9 mM K +. After the ni fedipine-induced relaxation had reached a plateau
.... .. + Nif 10-7 M (40 min) .• ET was added cumulatively, and the result is shown in Fig. 2 . Inhibitory effects of nifedipine were more potent in the basilar artery than in the mesenteric artery. In the presence of nifedipine, contractile responses of the basilar artery to lower concentrations (below 3 x 10-1 0 M) of ET were abolished. When the concentration-response curves for ET in the presence of 10 -7 M nifedipine were compared between the basilar and mesenteric arteries, threshold concentrations, -log EC50 val ues, or maximum responses (relative to the 65.9 mM K + -induced contraction) were similar in the two arteries (Fig. 2) .
Relaxant responses to nifedipine were then deter mined in strips precontracted with 10-9 M ET (Fig.  3) . The contractile response of the basilar and PC arteries to 10 -9 M ET was rapid in onset when com pared with that of the mesenteric artery. The addi tion of nifedipine caused a concentration-dependent relaxation in these arteries. Relaxant responses to nifedipine were significantly greater in the basilar and PC arteries than in the mesenteric artery ( Fig. 4 ).
When these arteries were precontracted with 10-8 M ET, relaxant responses to 10-7 M nifed ipine were significantly weaker than the case of 10-9 M ET (Figs. 3 and 5). Under these conditions, the relaxant response to 10-7 M nifedipine was sig nificantly greater in the basilar (43.1 ± 10.0% of the maximum relaxation induced by papaverine, n = 7) and PC (42.5 ± 10.6%, n = 7) arteries than in the mesenteric artery (29.4 ± 11.0%, n = 7).
Enhancement by ET of Ca 2 + -induced contractions
The basilar artery, but not the mesenteric artery, relaxed significantly from the resting level when placed in a O-Ca solution (Fig. 6A ). The magnitude of the basilar arterial relaxation induced by Ca2 + removal was 23.9 ± S.7% (n = 45) of the contrac tion induced by 65.9 mM K +. After the 40-min ex posure to the O-Ca solution, the addition to the bas ilar artery of 2.5 mM Ca2+ caused a biphasic con traction, composed of an initial rapid phase and an ensuing slow phase, which were separated by a sig nificant transient relaxation (Fig. 6A) . It is notewor thy that the readdition of Ca2 + to the O-Ca solution restored completely the relaxation induced by Ca2 + removal. When lO -8 M nifedipine was introduced before the Ca2+ -induced contraction, this blocker inhibited the rapid phase completely and the slow phase partially (Fig. 6B ). The slow phase was abol ished by lO-7 M nifedipine (Fig. 6C ). In the mes enteric artery, there was no such contraction by the readdition of Ca2+ (Fig. 6D-F) . When lO-9 M ET was introduced before the Ca2 + -induced contraction in the basilar artery, this peptide produced only a very small contraction, but J Cereb Blood Flow Me/ab. Vol. 11. No.3. /99/ significantly enhanced both phases of the Ca2+ induced contraction (Fig. 7 A) . In the presence of lO-9 M ET, the addition of 2.5 mM Ca2+ caused a biphasic contraction in the mesenteric artery (Fig.  7C) . The rapid and slow phases of the Ca2+ -induced contraction in the absence and presence of ET are shown in Table 1 . In the presence of 10-9 M ET, each phase of the Ca2 + -induced contraction was significantly greater in the basilar artery than in the mesenteric artery. In the PC artery, results similar to the case of the basilar artery were obtained (Ta ble I).
The effects of the treatment with 10-7 M nifed ipine on the lO-9 M ET-induced enhancement of the Ca2 + -induced contraction are also shown in Fig. 7B and D. Nifedipine inhibited both phases of the Ca2 + -induced contraction. The extent of the in hibition by nifedipine was significantly greater in the basilar artery than in the mesenteric artery ( Fig.  7 , Table 1 ). The inhibitory effect of nifedipine in the basilar artery was greater in the slow phase than in the rapid phase, while in the mesenteric artery, that was similar in the two phases ( Fig. 7, Table 1 ). In the PC artery, ET -induced enhancement of the Ca2+ -induced contraction was markedly inhibited by lO-7 M nifedipine (Table 1) .
When lO-8 M ET was added to the O-Ca solution, a transient contraction was observed in the basilar (Fig. SA) and mesenteric (Fig. SB) arteries. The magnitude of the lO -8 M ET -induced contraction in the O-Ca solution was significantly smaller in the basilar artery (24.4 ± 4.9% of the contraction in duced by 65.9 mM K +, n = 14) than in the mesen teric artery (34.2 ± 13.S%, n = 14). Under these conditions, the addition of 2.5 mM Ca2+ caused a monophasic contraction in these arteries ( Fig. SA  and C) . This contraction was not significantly dif ferent between the two arteries (Table 1) . Nifed ipine also inhibited the lO -8 ME T-induced en hancement of the Ca2+ -induced contraction ( Fig.  SB and D) . The extent of the inhibition by nifedipine was significantly greater in the basilar artery (46. S ± 11.1 %, n = 7) than in the mesenteric artery (25.4 ± S.5%, n = 7) (Fig. S) . In the presence of 10-7 M nifedipine, the remaining Ca2+ -induced contraction was not significantly different between the two ar teries (Table 1) .
DISCUSSION
The present study demonstrates that ET has mul tiple sites of action on arterial smooth muscle in cluding nifedipine-sensitive Ca2+ influx through the activation of VDCs, nifedipine-insensitive Ca2+ in flux (presumably ET receptor-operated Ca2 + in- to stimulation with lower concentrations (below 3 x 10-10 M) of ET and these enhanced contractions were dependent to a large extent on Ca2 + influx through VDCs. This conclusion comes from the fol lowing observations: (a) contractile responses of the basilar artery to lower concentrations to ET were abolished either by treatment with nifedipine or in the O-Ca solution; (b) in the presence of 10-7 M nifedipine, remaining contractile responses to ET were similar in the basilar and mesenteric arteries; (c) the relaxant effect of nifedipine on 10 -9 M ET induced contraction was greater in the cerebral ar teries than in the mesenteric artery; (d) cerebral ar teries but not the mesenteric artery relaxed from the resting level when placed in a O-Ca solution; and (e) the readdition of Ca2 + to the cerebral arteries placed in the O-Ca solution caused a biphasic con traction that is highly sensitive to nifedipine. It has been reported that ET has mUltiple sites of actions (Yanagisawa and Masaki, 1989a,b) . Early studies have demonstrated that the vascular con tractile responses to ET were dependent to a large extent on extracellular Ca2+ and were inhibited by dihydropyridine Ca2+ channel blockers (Hirata et aI., 1988; Yanagisawa et aI., 1988; Goto et aI., 1989; Saito et aI., 1989) . Based on these findings and the structural similarities existing with some neurotox ins active on ion channels, it has been suggested that ET could act as an endogenous agonist for VDCs (Yanagisawa et aI., 1988; Yanagisawa and Masaki, 1989a,b) . However, radio ligand binding studies have clearly demonstrated that the ET bind ing is not displaced by any of the organic Ca2+ channel blockers, including nifedipine, diltiazem, and verapamil, nor does ET displace specifically bound Ca2+ channel blockers (Hirata et aI., 1988; Chabrier et aI., 1989; Gu et aI., 1989a,b; Kasuya et aI., 1989) . Therefore, ET appears to produce vaso constriction via ultimately accelerating Ca2 + influx
FIG. 6. Typical recordings of the Ca2+ -induced contraction in strips of basilar and mesenteric arteries placed in a O-Ca solution, and its inhi bition by nifedipine (Nif). Three strips of each artery were prepared from the same animal and subjected to different treatments. Note the ini tial contractile response to the PSS containing 65.9 mM K+ (65.9 K). Following washout, the PSS was replaced with a O-Ca solution (\7) for 40 min, and then 2.5 mM Ca2+ (Ca) was added to the O-Ca solution in the first strip (A,D). In the second (B,E) and third (C,F) strips, Nif at 10-8
and 10-7 M was added 20 min before the addi tion of 2.5 mM Ca2+.
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Nit 7 Co through VDCs but that the binding site is distinct from that of dihydropyridines (Kasuya et aI., 1989) . Hirata et aI. (1988) reported the presence of specific receptors for ET that were affected by neither the well-known vasoconstrictor hormones, peptide neurotoxins, nor Ca 2 + channel blockers. The exis tence of nifedipine-insensitive components of the ET-induced Ca2+ influx in vascular smooth muscle has also been demonstrated (Chabrier et aI., 1989; Wallnofer et aI., 1989; Inoue et aI., 1990) . In addi tion to these Ca2+ influx accelerating activities, ET has been shown to accelerate the release of Ca2 + from intracellular storage sites (Miasiro et aI., 1988; Resink et aI., 1988; Van Renterghem et aI., 1988; Kai et aI., 1989; Takuwa et aI., 1989) . From these observations, it may be concluded that although ET has a variety of actions on vascular smooth muscle, the contribution of each action to the contractile Basilar A responses to ET may vary from one artery to an other. It also is likely that the mechanism of action of ET depends on the concentration used.
In the present study, contractile responses to lower concentrations (below 1 x 10-9 M) of ET were dependent to a large extent on extracellular Ca2 + , because these concentrations of ET failed to contract the arteries in a O-Ca solution. At relatively high concentrations (above 1 x 10-8 M), ET also acted on intracellular Ca2 + stores. The nifedipine sensitive component of the ET-induced contraction (presumably due to the activation of VDCs) was always greater in the cerebral arteries than in the mesenteric artery. Especially, contractile responses of the cerebral arteries to lower concentrations of ET were highly sensitive to nifedipine. Although the maximum contractions induced by ET were similar in the cerebral and mesenteric arteries, a Fig. 6 except that 10-9 M ET was added 10 min after the re placement with a O-Ca solution. Two strips of each artery were prepared from the same animal and subjected to different treatments. r- threshold concentration and -log EC50 value for ET were significantly lower in the cerebral arteries than in the mesenteric artery. Similar sensitivity to ET has been reported in feline middle cerebral ar teries (Jansen et al., 1989; Saito et al., 1989) . The nifedipine-insensitive components (presumably ET receptor-operated Ca2+ influx) were roughly the same in these arteries. A likely possibility for the enhanced responses to lower concentrations of ET in the cerebral arteries appears to be that these arteries are more depolar ized than the mesenteric artery. No measurements of the resting membrane potential are available in the present study; the electrical properties of the smooth muscles of canine cerebral and mesenteric arteries have already been demonstrated. The rest ing membrane potential of the smooth muscle of cerebral arteries was found to be about -50 m V (Fujiwara et al., 1982a,b; Suzuki and Fujiwara, 1982) . On the other hand, the resting membrane po tential of the mesenteric artery was about -68 m V (Kou et al., 1982; Inoue et al., 1984) . Thus, the resting membrane potential of the smooth muscle of canine cerebral arteries is much higher than that of the mesenteric artery. This is because the cerebral arteries have a higher resting K + conductance than the mesenteric artery (Fujiwara et al., 1982b; Asano et al., 1989a) . It is thus possible that one arterial preparation has a different resting membrane poten tial than another; then the response to the very same agonist, ET in the present study, would be quite different. Because the degree of membrane depolarization influences the state of activation of VDCs, VDCs in the cerebral arteries are more ac tivated than those in the mesenteric artery. In the porcine coronary artery, contractile responses to ET have been demonstrated to be competitively an tagonized by nicardipine (Yanagisawa et aI., 1988; Kasuya et aI., 1989) . The resting membrane poten tial of this artery was about -53 m V (Kasuya et aI., 1989) . These observations strongly suggest an exis tence of the activated state of VDCs in the porcine coronary artery. Thus, the Ca2+ influx accelerating activity of ET appeared to predominate in the ar teries with higher resting membrane potentials in cluding canine cerebral arteries and the porcine cor onary artery. Basically, similar changes were observed in our previous study in which the contractile responses to Bay k 8644, a dihydropyridine Ca2+ channel ago nist, were compared between the strips of cerebral and peripheral arteries of the dog (Asano et al., 1987) . Bay k 8644 produced a concentration dependent contraction much greater in the cerebral arteries than in the mesenteric artery. Thus, it is interesting to note the similarities between the re sponses to ET in the present study and those to Bay k 8644 in our previous study (Asano et aI., 1987) . It also is interesting to note that the cerebral arteries are highly sensitive to Ca2+ channel blockers (Ha yashi and Toda, 1977; Allen and Banghart, 1979; Shimizu et al., 1980; Towart, 198 1; Cauvin et aI., 1983) . These observations may support the exis tence of the activated state of the VDCs in the rest ing state of cerebral arteries.
The conclusion that VDCs in the cerebral arteries are in different states of activation from those in the mesenteric artery also is derived from the nifedipine experiments. Nifedipine produced a relaxation re sponse from the resting tone of the cerebral arter ies, but not in the mesenteric artery. Furthermore, when the basal tone in the basilar artery was elim inated by the addition of 10-7 M nidefipine, the remaining responses to ET in the basilar artery were comparable to those in the mesenteric artery determined under the same conditions.
In the absence of any contractile agent, the read dition of Ca2+ to the cerebral arteries placed in a O-Ca solution caused a nifedipine-sensitive biphasic contraction. These Ca2+ -induced contractions have never been observed in the mesenteric artery. ET (10-9 M) enhanced the Ca2+ -induced contractions. The extent of the enhancement was greater in the J Cereb Blood Flow Me/ab, Vol. 11, No.3, 1991 cerebral arteries than in the mesenteric artery. Ni· fedipine inhibited the ET-induced enhancement. The extent of the inhibition also was greater in the cerebral arteries than in the mesenteric artery. Un der the same experimental conditions, the nifed ipine-insensitive components of the ET -induced Ca2+ contraction were similar among the cerebral and mesenteric arteries. Thus, in the canine mesen teric artery, the Ca2+ influx accelerating activity of ET may play a less important role than the ability of this peptide to release Ca2+ from storage sites.
In conclusion, the present study compared the ability of ET to cause a contraction between the cerebral and peripheral arteries. At the lower con centration range (below 10-9 M), ET produced a contraction much greater in the cerebral arteries than in the mesenteric artery. These enhanced re sponses to ET were dependent to a large extent on extracellular Ca2 + and were markedly inhibited by nifedipine. The inhibition by nifedipine of the re sponses to ET was always greater in the cerebral arteries than in the mesenteric artery. The en hanced responses to ET in the cerebral arteries may be explained by the difference in the resting mem brane potential between these arteries and therefore the difference in the state of activation of VDCs.
